Clinical Trials
88 trialsA Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation
Icahn School of Medicine at Mount Sinai
Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC
Fudan University
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk
ChineseAMS
Total Neoadjuvant Therapy in Rectal Cancer Treatment
State Scientific Centre of Coloproctology, Russian Federation
Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma
European Organisation for Research and Treatment of Cancer - EORTC
LUNG ART
Gustave Roussy, Cancer Campus, Grand Paris
The Clinical Study of Adjuvant Chemotherapy on Intestinal and Urethral Flora in Patients With Gastric and Colon Cancer
The First Affiliated Hospital of Dalian Medical University
EHTASEOCCS
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy
Royal Marsden NHS Foundation Trust
REALIZATION
Peking University
EPHOS-B
Institute of Cancer Research, United Kingdom
TACT2
Institute of Cancer Research, United Kingdom
TNTCRT
West China Hospital
EHNPCTASEOC
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Clinical Effect of Neoadjuvant Hierarchical Treatment Based on Chemotherapy
Harbin Medical University
ST03
Medical Research Council
HIPEC
Sixth Affiliated Hospital, Sun Yat-sen University
Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection
Sun Yat-sen University
Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer
ChineseAMS
Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer
Shanghai Chest Hospital
Randomized Control Trial on Efficacy and Safety of Concurrent and Adjuvant Chemotherapy for the Cervical Cancer
Air Force Military Medical University, China
A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma
Shandong Cancer Hospital and Institute
A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection.
ChineseAMS
Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer
Sun Yat-sen University
Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma
European Organisation for Research and Treatment of Cancer - EORTC
Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After Chemotherapy
Sun Yat-sen University
Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor
National Cancer Institute (NCI)
Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
National Cancer Institute (NCI)
Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma
National Cancer Institute (NCI)
Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
National Cancer Institute (NCI)
Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
National Cancer Institute (NCI)
Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
National Cancer Institute (NCI)
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
National Cancer Institute (NCI)
Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma
National Cancer Institute (NCI)
Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
National Cancer Institute (NCI)
Tamoxifen in Treating Women With Breast Cancer
National Cancer Institute (NCI)
Lymphocyte Therapy in Treating Patients With Kidney Cancer
National Cancer Institute (NCI)
Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer
National Cancer Institute (NCI)
R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
National Cancer Institute (NCI)
Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed
National Cancer Institute (NCI)
Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Colon Cancer
National Cancer Institute (NCI)
Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain Tumors
National Cancer Institute (NCI)
S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer
National Cancer Institute (NCI)
S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer
National Cancer Institute (NCI)
Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors
National Cancer Institute (NCI)
Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery
National Cancer Institute (NCI)
Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer
National Cancer Institute (NCI)
High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma
National Cancer Institute (NCI)